These vaccines-Arexvy by GSK and Abrysvo by Pfizer—are the first for RSV. The new vaccines come with common vaccine side effects including swelling or pain at the injection site, fever, and headache, ...
This is the first RSV vaccine approved in Singapore for use in older adults and pregnant individuals, providing critical ...
Pfizer Singapore announced that the Health Sciences Authority has approved the company’s Abryvso vaccine for respiratory ...
MILLIONS of Brits have been urged to book a lifesaving new jab that offers 86 per cent protection against a killer lung ...
Reformulated flu and COVID-19 shots are available to Oregonians starting this month. And an RSV vaccine — developed only last ...
The Surry County Health and Nutrition Center is offering two FDA-approved vaccines to protect against Respiratory Syncytial Virus (RSV): Abrysvo and Beyfortus.
Respiratory syncytial virus, or RSV, season is just a few months away, but new vaccine options have already arrived for ...
Respiratory syncytial virus, or RSV, season is just a few months away, but new vaccine options have already arrived for ...
Vicebio has raised $100m in a Series B funding round led by TCGX. Credit: MargJohnsonVA via Shutterstock. UK-based startup ...
Results looking at the first season of RSV use shows that it is 75% effective at preventing RSV-associated hospitalizations ...
The respiratory syncytial virus (RSV) space may have filled up over the past year, but that isn’t deterring Vicebio or its ...
The first RSV vaccines were approved in the US in May last year. GSK’s Arexvy vaccine generated more than $1bn in sales in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback